<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Muscle-eye-<z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disease</z:e> (MEB) and Walker Warburg Syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e>) belong to a spectrum of <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> diseases characterized by ocular dysgenesis, neuronal migration defects, and <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Until now, the pathophysiology of MEB/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> has been attributed to alteration in dystroglycan post-translational modification </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we provide evidence that mutations in a gene coding for a major basement membrane protein, collagen IV alpha 1 (COL4A1), are a novel cause of MEB/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Using a combination of histological, molecular, and biochemical approaches, we show that heterozygous Col4a1 mutant mice have ocular dysgenesis, neuronal localization defects, and <z:hpo ids='HP_0003198'>myopathy</z:hpo> characteristic of MEB/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Importantly, we identified putative heterozygous mutations in COL4A1 in two MEB/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> patients </plain></SENT>
<SENT sid="5" pm="."><plain>Both mutations occur within conserved amino acids of the triple-helix-forming domain of the protein, and at least one mutation interferes with secretion of the mutant proteins, resulting instead in intracellular accumulation </plain></SENT>
<SENT sid="6" pm="."><plain>Expression and posttranslational modification of dystroglycan is unaltered in Col4a1 mutant mice indicating that COL4A1 mutations represent a distinct pathogenic mechanism underlying MEB/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>These findings implicate a novel gene and a novel mechanism in the etiology of MEB/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> and expand the clinical spectrum of COL4A1-associated disorders </plain></SENT>
</text></document>